Article Details
Retrieved on: 2024-06-25 15:33:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £152.00....
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here